Cultivar Capital’s Gilead Sciences GILD Stock Holding History

Cultivar Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-170	Closed	-$11.7K	–	91
2024 Q2	$11.7K	Buy	+170	New	+$11.3K	0.01%	125

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cultivar Capital's GILD Position: Q3 2024 in Review

Cultivar Capital sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 170 shares — an estimated $11.7K sold.

Cultivar Capital first reported a position in GILD in Q2 2024 and held it in 1 quarter. The position peaked at $11.7K in Q2 2024. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

Cultivar Capital reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
Cultivar Capital sold 170 Gilead Sciences shares in Q3 2024, an estimated $11.7K.
Cultivar Capital first reported a position in Gilead Sciences in Q2 2024 and held it in 1 quarter.
Cultivar Capital's Gilead Sciences position peaked at $11.7K in Q2 2024.
1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Cultivar Capital's 13F filing for Q3 2024, filed 16 Oct 2024.